• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对由甲状腺球蛋白水平的生理调节诱导的实验性自身免疫性甲状腺炎的抵抗

Resistance to experimental autoimmune thyroiditis induced by physiologic manipulation of thyroglobulin level.

作者信息

Lewis M, Giraldo A A, Kong Y C

出版信息

Clin Immunol Immunopathol. 1987 Oct;45(1):92-104. doi: 10.1016/0090-1229(87)90115-2.

DOI:10.1016/0090-1229(87)90115-2
PMID:3113790
Abstract

The role of circulatory mouse thyroglobulin (MTg) level in activating mechanisms suppressive to induction of experimental autoimmune thyroiditis (EAT) was studied by two regimens to strengthen normal maintenance of self-tolerance in genetically susceptible mice. One was to administer graded doses of exogenous MTg either 7 days apart or daily for 10 days and then challenge the animals with MTg + LPS. The other was to infuse TSH via an osmotic pump for 7 days. The steady TSH infusion for 7 days resulted in an increase in MTg level peaking on Day 3. Such kinetics of MTg concentration in response to TSH coincided with enhanced resistance to EAT induction. After an initial rapid clearance rate of t1/2 of 3 hr, tolerogenic doses of exogenous MTg sustained similar levels for 2-3 days. In contrast, subtolerogenic doses declined to baseline levels in 2 days or less. Clearance can be best explained by a two-compartment model for distribution with an initial alpha phase (t1/2 about 3 hr), followed by a beta phase (t1/2 about 10 hr). We conclude that, for the prevention of EAT induction in the presence of potent adjuvants (CFA or LPS), a threshold, but above baseline, level of either exogenous or endogenous MTg, represented by the beta phase, is required for a critical period (greater than 2-3 days) to activate suppressor mechanisms over and above homeostatic regulation. Whether MTg concentration raised by TSH (TRH) administration activates suppressor T cells as observed after the injection of a tolerogenic dose of MTg remains to be determined.

摘要

通过两种方案研究了循环小鼠甲状腺球蛋白(MTg)水平在激活抑制实验性自身免疫性甲状腺炎(EAT)诱导机制中的作用,以加强遗传易感小鼠自身耐受性的正常维持。一种方案是每隔7天或连续10天每天给予不同剂量的外源性MTg,然后用MTg+脂多糖(LPS)攻击动物。另一种方案是通过渗透泵输注促甲状腺激素(TSH)7天。持续7天输注TSH导致MTg水平在第3天达到峰值。MTg浓度对TSH的这种动力学变化与对EAT诱导的抵抗力增强相吻合。外源性MTg的耐受剂量在最初快速清除率(半衰期t1/2为3小时)后,在2 - 3天内维持相似水平。相比之下,亚耐受剂量在2天或更短时间内降至基线水平。清除过程可以用一个两室分布模型最好地解释,即最初的α相(半衰期约3小时),随后是β相(半衰期约10小时)。我们得出结论,为了在存在强效佐剂(完全弗氏佐剂或LPS)的情况下预防EAT诱导,在关键时期(大于2 - 3天),需要一个高于基线的外源性或内源性MTg阈值水平(以β相表示)来激活超过稳态调节的抑制机制。通过给予TSH(促甲状腺激素释放激素)提高的MTg浓度是否如注射耐受剂量的MTg后所观察到的那样激活抑制性T细胞仍有待确定。

相似文献

1
Resistance to experimental autoimmune thyroiditis induced by physiologic manipulation of thyroglobulin level.对由甲状腺球蛋白水平的生理调节诱导的实验性自身免疫性甲状腺炎的抵抗
Clin Immunol Immunopathol. 1987 Oct;45(1):92-104. doi: 10.1016/0090-1229(87)90115-2.
2
Characterization of resistance to murine experimental autoimmune thyroiditis: duration and afferent action of thyroglobulin- and TSH-induced suppression.对小鼠实验性自身免疫性甲状腺炎抗性的特征:甲状腺球蛋白和促甲状腺激素诱导抑制的持续时间及传入作用
Clin Immunol Immunopathol. 1993 Oct;69(1):60-8. doi: 10.1006/clin.1993.1150.
3
Resistance to experimental autoimmune thyroiditis is correlated with the duration of raised thyroglobulin levels.
Clin Immunol Immunopathol. 1992 Sep;64(3):197-204. doi: 10.1016/0090-1229(92)90200-8.
4
Resistance to experimental autoimmune thyroiditis: L3T4+ cells as mediators of both thyroglobulin-activated and TSH-induced suppression.对实验性自身免疫性甲状腺炎的抵抗:L3T4 + 细胞作为甲状腺球蛋白激活和促甲状腺激素诱导抑制的介质。
Clin Immunol Immunopathol. 1989 Apr;51(1):38-54. doi: 10.1016/0090-1229(89)90204-3.
5
Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1 beta.重组白细胞介素-1β对小鼠实验性自身免疫性甲状腺炎中耐药诱导的规避作用
J Immunol. 1992 Aug 1;149(3):1086-92.
6
Synergism between mouse thyroglobulin- and vaccination-induced suppressor mechanisms in murine experimental autoimmune thyroiditis.小鼠甲状腺球蛋白与疫苗接种诱导的抑制机制在小鼠实验性自身免疫性甲状腺炎中的协同作用。
Cell Immunol. 1991 Sep;136(2):340-8. doi: 10.1016/0008-8749(91)90357-h.
7
IL-12 prevents tolerance induction with mouse thyroglobulin by priming pathogenic T cells in experimental autoimmune thyroiditis: role of IFN-gamma and the costimulatory molecules CD40l and CD28.白细胞介素-12通过在实验性自身免疫性甲状腺炎中激活致病性T细胞来阻止小鼠甲状腺球蛋白诱导的免疫耐受:γ干扰素以及共刺激分子CD40L和CD28的作用
Cell Immunol. 2001 Feb 25;208(1):52-61. doi: 10.1006/cimm.2001.1767.
8
Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines.静脉注射去聚合的小鼠甲状腺球蛋白可抑制实验性自身免疫性甲状腺炎的诱导以及Th1和Th2细胞因子的表达。
Int Immunol. 1997 May;9(5):679-87. doi: 10.1093/intimm/9.5.679.
9
The role of cellular proliferation in the induction of experimental autoimmune thyroiditis (EAT) in mice.
Cell Immunol. 1986 Nov;103(1):96-104. doi: 10.1016/0008-8749(86)90071-7.
10
Suppression in experimental autoimmune thyroiditis: the role of unique and shared determinants on mouse thyroglobulin in self-tolerance.实验性自身免疫性甲状腺炎中的抑制作用:小鼠甲状腺球蛋白上独特和共享决定簇在自身耐受中的作用。
Cell Immunol. 1990 Nov;131(1):140-9. doi: 10.1016/0008-8749(90)90241-i.

引用本文的文献

1
Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1.由免疫检查点抑制剂抗CTLA-4和抗PD-1引发的机会性自身免疫性疾病
Front Immunol. 2014 May 16;5:206. doi: 10.3389/fimmu.2014.00206. eCollection 2014.
2
Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.打破对甲状腺抗原的耐受性:甲状腺自身免疫中概念的改变。
Endocr Rev. 2014 Feb;35(1):59-105. doi: 10.1210/er.2013-1055. Epub 2013 Dec 4.
3
Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function.
自身免疫性甲状腺炎:一种特别适合探究调节性 T 细胞功能的模型。
J Autoimmun. 2009 Nov-Dec;33(3-4):239-46. doi: 10.1016/j.jaut.2009.09.004. Epub 2009 Oct 12.
4
Attenuation of induced hyperthyroidism in mice by pretreatment with thyrotropin receptor protein: deviation of thyroid-stimulating to nonfunctional antibodies.用促甲状腺激素受体蛋白预处理对小鼠诱导性甲状腺功能亢进的减弱作用:促甲状腺刺激抗体向无功能抗体的转变
Endocrinology. 2009 Aug;150(8):3944-52. doi: 10.1210/en.2009-0181. Epub 2009 Apr 23.
5
Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen.天然存在的CD4(+)CD25(+)Foxp3(+)调节性T细胞对于由外源性或内源性自身抗原诱导的实验性自身免疫性甲状腺炎的耐受性是必需的。
J Autoimmun. 2009 Aug;33(1):68-76. doi: 10.1016/j.jaut.2009.03.010. Epub 2009 Apr 17.
6
Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy.自身免疫性甲状腺炎作为癌症免疫治疗期间自身免疫后遗症的指标。
Autoimmun Rev. 2009 Sep;9(1):28-33. doi: 10.1016/j.autrev.2009.02.034. Epub 2009 Feb 28.
7
Chronic exposure in vivo to thyrotropin receptor stimulating monoclonal antibodies sustains high thyroxine levels and thyroid hyperplasia in thyroid autoimmunity-prone HLA-DRB1*0301 transgenic mice.在易患甲状腺自身免疫的HLA - DRB1*0301转基因小鼠体内,长期暴露于促甲状腺素受体刺激单克隆抗体可维持高甲状腺素水平和甲状腺增生。
Immunology. 2007 Oct;122(2):261-7. doi: 10.1111/j.1365-2567.2007.02635.x. Epub 2007 May 29.
8
Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice.在人类白细胞抗原DR3(DRB1*0301)转基因II类敲除非肥胖糖尿病小鼠中,CD4+CD25+调节性T细胞的耗竭会加剧碘化钠诱导的实验性自身免疫性甲状腺炎。
Clin Exp Immunol. 2007 Mar;147(3):547-54. doi: 10.1111/j.1365-2249.2006.03303.x.
9
Abnormalities in the SJL mouse provide evidence for different mechanisms for the induction and transfer of tolerance to mouse thyroglobulin.SJL小鼠的异常情况为诱导和传递对小鼠甲状腺球蛋白的耐受性的不同机制提供了证据。
Immunology. 1989 Jan;66(1):106-10.
10
Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells.抗肿瘤免疫与自身免疫:调节性T细胞的平衡行为
Cancer Immunol Immunother. 2004 Feb;53(2):73-8. doi: 10.1007/s00262-003-0444-1. Epub 2003 Nov 11.